Imran Junaid, MD
Allergy/Immunology · Concord
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 20
- 4 carriers
- Offices
- 16
Offices
16 locations · Jiva Health Inc · 46 clinicians in this group
Plans that list them
20 plans · 4 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Junaid’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
20 of 20 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A103029 · Current
Licensed to practise in California · since 2008 · expires 2027-07-31 · Ross University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$1,351,103
Medicare paid this office $1,351,103 for 787 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Injection, tezepelumab-ekko, 1 mg | 19 | $332,258 | None |
| Injection, mepolizumab, 1 mg | 13 | $271,991 | None |
| Injection, omalizumab, 5 mg | 11 | $101,222 | None |
| Return visit (30+ min) | 345 | $94,493 | $111 |
| Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month | 130 | $77,815 | $132 |
See all 27 services
| Injection, tezepelumab-ekko, 1 mg | 19 | $332,258 | None |
| Injection, mepolizumab, 1 mg | 13 | $271,991 | None |
| Injection, omalizumab, 5 mg | 11 | $101,222 | None |
| Return visit (30+ min) | 345 | $94,493 | $111 |
| Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month | 130 | $77,815 | $132 |
| Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | 141 | $52,672 | $38 |
| Professional service for preparation and provision of 1 or more antigens | 113 | $51,952 | $15 |
| Short return visit (20+ min) | 317 | $51,331 | $75 |
| Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | 146 | $47,647 | $52 |
| Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | 152 | $47,280 | $48 |
| Professional service for multiple injections of allergen | 113 | $20,757 | $12 |
| Test for allergy using allergenic extract | 56 | $14,347 | $4 |
| New patient visit (30+ min) | 112 | $9,396 | $84 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 68 | $8,819 | $57 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 50 | $7,863 | $157 |
| Injection of drug or substance under skin or into muscle | 72 | $6,478 | $14 |
| New patient visit (45+ min) | 50 | $6,169 | $123 |
| Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 17 | $3,357 | $197 |
| Long return visit (40+ min) | 18 | $2,721 | $143 |
| Test for allergy using allergenic extract injected into skin | 32 | $2,708 | $9 |
| Professional service for single injection of allergen | 23 | $2,686 | $10 |
| Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19), influenza virus types a and b, and respiratory syncytial virus | 12 | $1,817 | $140 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 94 | $1,803 | $15 |
| Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | 71 | $1,533 | $22 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 22 | $973 | $31 |
| Test to measure expiratory airflow and volume | 29 | $882 | $18 |
| Administration of influenza virus vaccine | 12 | $464 | $39 |
Who their Medicare patients are
787 Original Medicare patients in 2024. Average age 71 · Under 65 15% · 85 and older 6% · Women 62% · Also on Medicaid 33% · Health risk score 1.15. Above the middle of the specialty; the typical allergy/ immunology clinician is at 1.
Conditions among them: High blood pressure 73% · Diabetes 37% · Depression 24% · Chronic kidney disease 21% · Coronary heart disease 19% · COPD 16% · Heart failure 12% · Cancer 12% · Atrial fibrillation 12% · Stroke 8% · Dementia 4%.
The office billed $3,288,531, Medicare allowed $1,713,907 and paid $1,351,103; for 65,857 services of 58 kinds; $829,611 of it was for drugs given in the office and $521,493 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 787 | 65,857 | 71 | 1.15 | $3,288,531 | $1,351,103 |
| 2023 | 534 | 44,283 | 70 | 1.09 | $2,571,024 | $1,003,269 |
| 2022 | 632 | 38,518 | 71 | 1.04 | $2,678,923 | $999,884 |
| 2021 | 632 | 35,350 | 71 | 1.03 | $2,451,363 | $971,857 |
| 2020 | 329 | 21,857 | 72 | 1.03 | $1,558,959 | $588,966 |
| 2019 | 334 | 16,435 | 72 | 1.03 | $1,114,015 | $438,535 |
| 2018 | 65 | 953 | 73 | 1.02 | $35,559 | $15,904 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 24 services
| Injection, mepolizumab, 1 mg | 18 | $242,044 | None |
| Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month | 104 | $66,978 | $127 |
| Professional service for preparation and provision of 1 or more antigens | 112 | $52,277 | $16 |
| Return visit (30+ min) | 205 | $41,594 | $103 |
| Short return visit (20+ min) | 202 | $38,279 | $76 |
| Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | 108 | $37,677 | $37 |
| Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | 109 | $36,838 | $54 |
| Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | 116 | $32,544 | $47 |
| Professional service for multiple injections of allergen | 110 | $18,817 | $12 |
| Test for allergy using allergenic extract | 56 | $17,315 | $4 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 65 | $8,787 | $58 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 34 | $5,259 | $155 |
| Injection of drug or substance under skin or into muscle | 48 | $5,039 | $14 |
| New patient visit (30+ min) | 55 | $4,912 | $89 |
| New patient visit (45+ min) | 33 | $3,957 | $120 |
| Test for allergy using allergenic extract injected into skin | 38 | $3,310 | $9 |
| Long return visit (40+ min) | 19 | $3,306 | $150 |
| Professional service for single injection of allergen | 23 | $3,094 | $10 |
| Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | 57 | $1,188 | $20 |
| Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | 20 | $949 | $45 |
| Test to measure expiratory airflow and volume | 19 | $708 | $25 |
| Administration of influenza virus vaccine | 16 | $585 | $37 |
| Short return visit | 14 | $468 | $33 |
| Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | 16 | $350 | $22 |
2022: 25 services
| Injection, mepolizumab, 1 mg | 18 | $253,345 | None |
| Injection, omalizumab, 5 mg | 17 | $163,299 | None |
| Professional service for preparation and provision of 1 or more antigens | 157 | $73,300 | $16 |
| Short return visit (20+ min) | 355 | $60,790 | $70 |
| Return visit (30+ min) | 259 | $55,156 | $105 |
| Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month | 68 | $37,548 | $125 |
| Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | 81 | $31,091 | $38 |
| Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | 77 | $24,582 | $57 |
| Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | 87 | $22,728 | $47 |
| Professional service for multiple injections of allergen | 143 | $20,609 | $11 |
| Test for allergy using allergenic extract | 53 | $14,388 | $4 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 49 | $7,503 | $153 |
| Injection of drug or substance under skin or into muscle | 62 | $5,281 | $13 |
| Long return visit (40+ min) | 27 | $5,192 | $167 |
| New patient visit (45+ min) | 38 | $5,117 | $135 |
| Professional service for single injection of allergen | 44 | $3,470 | $9 |
| Test for allergy using allergenic extract injected into skin | 32 | $2,716 | $9 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 20 | $2,648 | $56 |
| New patient visit (30+ min) | 30 | $2,579 | $86 |
| Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | 24 | $1,663 | $69 |
| Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | 20 | $1,227 | $51 |
| Administration of influenza virus vaccine | 29 | $1,044 | $36 |
| Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | 51 | $1,003 | $20 |
| Test to measure expiratory airflow and volume | 32 | $867 | $24 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 14 | $231 | $14 |
2021: 26 services
| Injection, omalizumab, 5 mg | 20 | $208,936 | None |
| Injection, mepolizumab, 1 mg | 14 | $190,734 | None |
| Injection, benralizumab, 1 mg | 11 | $170,222 | None |
| Professional service for preparation and provision of 1 or more antigens | 167 | $101,073 | $16 |
| Short return visit (20+ min) | 386 | $81,702 | $83 |
| Return visit (30+ min) | 296 | $62,543 | $115 |
| Test for allergy using allergenic extract | 87 | $24,067 | $4 |
| Injection for rapid desensitization to allergen | 17 | $20,621 | $127 |
| Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | 59 | $13,803 | $61 |
| New patient visit (45+ min) | 93 | $13,194 | $142 |
| Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | 61 | $12,060 | $46 |
| Professional service for multiple injections of allergen | 156 | $11,000 | $11 |
| Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | 46 | $9,785 | $38 |
| Professional service for single injection of allergen | 110 | $9,583 | $8 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 44 | $6,898 | $157 |
| Injection of drug or substance under skin or into muscle | 57 | $6,175 | $14 |
| Long return visit (40+ min) | 20 | $3,917 | $163 |
| Sleep study including heart rate, breathing, airflow, and effort | 21 | $2,986 | $96 |
| Test for allergy using allergenic extract injected into skin | 36 | $2,844 | $9 |
| Prolonged preventive service(s) (beyond the typical service time of the primary procedure), in the office or other outpatient setting requiring direct patient contact beyond the usual service; first 30 minutes (list separately in addition to code for preve | 36 | $2,670 | $74 |
| New patient visit (30+ min) | 30 | $2,366 | $79 |
| Test to measure expiratory airflow and volume | 43 | $1,475 | $28 |
| Test for allergy using ingested items, initial 2 hours | 12 | $1,383 | $115 |
| Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | 23 | $1,231 | $51 |
| Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | 33 | $640 | $19 |
| Administration of influenza virus vaccine | 26 | $558 | $21 |
2020: 23 services
| Injection, mepolizumab, 1 mg | 11 | $174,761 | None |
| Injection, omalizumab, 5 mg | 11 | $169,933 | None |
| Return visit (30+ min) | 207 | $49,953 | $96 |
| Short return visit (20+ min) | 150 | $22,543 | $67 |
| Test for allergy using allergenic extract | 58 | $16,095 | $4 |
| Professional service for preparation and provision of 1 or more antigens | 25 | $15,358 | $15 |
| New patient visit (45+ min) | 94 | $12,471 | $133 |
| Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | 33 | $6,269 | $65 |
| Professional service for single injection of allergen | 83 | $5,605 | $9 |
| Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | 31 | $4,347 | $49 |
| Sleep study including heart rate, breathing, airflow, and effort | 18 | $4,244 | $118 |
| Injection of drug or substance under skin or into muscle | 31 | $4,171 | $14 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 27 | $3,740 | $139 |
| Prolonged preventive service(s) (beyond the typical service time of the primary procedure), in the office or other outpatient setting requiring direct patient contact beyond the usual service; first 30 minutes (list separately in addition to code for preve | 35 | $2,623 | $75 |
| Long return visit (40+ min) | 16 | $2,582 | $129 |
| Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 12 | $2,438 | $203 |
| Test for allergy using allergenic extract injected into skin | 28 | $2,312 | $8 |
| Test to measure expiratory airflow and volume | 40 | $1,535 | $35 |
| Influenza vaccine, inactivated | 21 | $1,306 | $59 |
| Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | 18 | $1,221 | $39 |
| Professional service for multiple injections of allergen | 30 | $848 | $11 |
| Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | 27 | $534 | $20 |
| Administration of influenza virus vaccine | 22 | $472 | $21 |
2019: 14 services
| Injection, omalizumab, 5 mg | 16 | $184,071 | None |
| Return visit (30+ min) | 241 | $64,416 | $96 |
| Short return visit (20+ min) | 149 | $23,450 | $65 |
| New patient visit (45+ min) | 110 | $14,327 | $130 |
| Test for allergy using allergenic extract | 49 | $13,480 | $4 |
| Sleep study including heart rate, breathing, airflow, and effort | 37 | $8,332 | $134 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 23 | $7,730 | $76 |
| Test to measure expiratory airflow and volume | 56 | $2,840 | $34 |
| Injection of drug or substance under skin or into muscle | 39 | $2,356 | $16 |
| Professional service for single injection of allergen | 41 | $2,142 | $9 |
| Test for allergy using allergenic extract injected into skin | 24 | $1,707 | $8 |
| Influenza vaccine, inactivated | 25 | $1,444 | $58 |
| Administration of influenza virus vaccine | 31 | $626 | $20 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 35 | $618 | $16 |
2018: 3 services
| Return visit (30+ min) | 29 | $3,683 | $100 |
| New patient visit (45+ min) | 13 | $1,830 | $141 |
| Short return visit (20+ min) | 24 | $1,828 | $68 |
Medicaid work
$668,734 in 2024
Medicaid paid $668,734 for 6,339 billed services this clinician did in 2024, up to 99 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| ANTIGEN THERAPY SERVICES | 99 | $231,916 |
| Return visit (30+ min) | 909 | $115,188 |
| Short return visit (20+ min) | 747 | $67,511 |
| Percutaneous tests (scratch, puncture, prick) with allergenic extracts, immediate type reaction, including test interpretation and report, specify number of tests | 216 | $60,239 |
| Injection, omalizumab, 5 mg | 27 | $56,999 |
| New patient visit (30+ min) | 303 | $38,624 |
| New patient visit (45+ min) | 201 | $36,021 |
| Professional services for allergen immunotherapy not including provision of allergenic extracts; 2 or more injections | 2,253 | $34,773 |
| Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular | 450 | $7,236 |
| IMMUNOTHERAPY ONE INJECTION | 424 | $5,386 |
| Remote physiologic monitoring treatment management services, clinical staff/physician/other qualified health care professional time in a calendar month requiring interactive communication with the patient/caregiver during the month; first 20 minutes | 224 | $4,158 |
| Remote monitoring of physiologic parameter(s) (eg, weight, blood pressure, pulse oximetry, respiratory flow rate), initial; device(s) supply with daily recording(s) or programmed alert(s) transmission, each 30 days | 212 | $4,122 |
| 2024 | 6,339 | 17 | 99 | $668,734 |
| 2023 | 4,435 | 14 | 81 | $247,853 |
| 2022 | 2,248 | 8 | 45 | $208,863 |
| 2021 | 3,412 | 11 | 89 | $406,281 |
| 2020 | 446 | 2 | 30 | $8,071 |
| 2019 | 116 | 2 | 25 | $1,984 |
See the largest Medicaid services in earlier years
2023
| Short return visit (20+ min) | 648 | $54,556 |
| ANTIGEN THERAPY SERVICES | 47 | $52,556 |
| Percutaneous tests (scratch, puncture, prick) with allergenic extracts, immediate type reaction, including test interpretation and report, specify number of tests | 181 | $46,434 |
| Return visit (30+ min) | 287 | $29,824 |
| Professional services for allergen immunotherapy not including provision of allergenic extracts; 2 or more injections | 1,662 | $21,147 |
| Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular | 472 | $13,379 |
| New patient visit (30+ min) | 116 | $12,079 |
| Remote monitoring of physiologic parameter(s) (eg, weight, blood pressure, pulse oximetry, respiratory flow rate), initial; device(s) supply with daily recording(s) or programmed alert(s) transmission, each 30 days | 220 | $4,706 |
| IMMUNOTHERAPY ONE INJECTION | 431 | $3,856 |
| Remote physiologic monitoring treatment management services, clinical staff/physician/other qualified health care professional time in a calendar month requiring interactive communication with the patient/caregiver during the month; first 20 minutes | 200 | $3,228 |
| Remote physiologic monitoring treatment management services, clinical staff/physician/other qualified health care professional time in a calendar month requiring interactive communication with the patient/caregiver during the month; each additional 20 minutes (List separately in addition to code for primary procedure) | 116 | $3,065 |
| New patient visit (45+ min) | 14 | $1,307 |
2022
| ANTIGEN THERAPY SERVICES | 77 | $99,258 |
| Short return visit (20+ min) | 389 | $30,723 |
| Injection, omalizumab, 5 mg | 14 | $29,400 |
| Return visit (30+ min) | 225 | $22,845 |
| Professional services for allergen immunotherapy not including provision of allergenic extracts; 2 or more injections | 1,016 | $14,587 |
| Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular | 394 | $8,534 |
| Percutaneous tests (scratch, puncture, prick) with allergenic extracts, immediate type reaction, including test interpretation and report, specify number of tests | 14 | $2,404 |
| IMMUNOTHERAPY ONE INJECTION | 119 | $1,112 |
2021
| Injection, omalizumab, 5 mg | 60 | $158,045 |
| ANTIGEN THERAPY SERVICES | 155 | $139,646 |
| Percutaneous tests (scratch, puncture, prick) with allergenic extracts, immediate type reaction, including test interpretation and report, specify number of tests | 195 | $31,543 |
| Return visit (30+ min) | 362 | $18,246 |
| Short return visit (20+ min) | 451 | $14,426 |
| New patient visit (45+ min) | 172 | $14,045 |
| IMMUNOTHERAPY ONE INJECTION | 1,172 | $7,879 |
| Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular | 308 | $7,193 |
| Professional services for allergen immunotherapy not including provision of allergenic extracts; 2 or more injections | 467 | $6,740 |
| RAPID DESENSITIZATION PROCEDURE EACH HOUR | 32 | $5,917 |
| New patient visit (30+ min) | 38 | $2,601 |
2020
| Return visit (30+ min) | 96 | $5,005 |
| IMMUNOTHERAPY ONE INJECTION | 350 | $3,067 |
2019
| Return visit (30+ min) | 19 | $1,214 |
| IMMUNOTHERAPY ONE INJECTION | 97 | $771 |
Drugs they prescribed that Part D paid
$40,027
Pharmacies billed $40,027 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 282) in 2024. At or below the middle of the specialty; the typical allergy/ immunology clinician is at 0%.
215 generic and 67 brand-name prescriptions · $40,027 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Trelegy Ellipta | 12 | $8,647 | $721 |
| Dulera | 11 | $4,300 | $391 |
| Albuterol Sulfate Hfa | 21 | $573 | $27 |
| Azelastine | 15 | $233 | $16 |
| Atorvastatin | 14 | $194 | $14 |
See all 7 drugs
| Trelegy Ellipta | 12 | $8,647 | $721 |
| Dulera | 11 | $4,300 | $391 |
| Albuterol Sulfate Hfa | 21 | $573 | $27 |
| Azelastine | 15 | $233 | $16 |
| Atorvastatin | 14 | $194 | $14 |
| Montelukast | 14 | $75 | $5 |
| Rosuvastatin | 15 | $47 | $3 |
Year by year
| 2024 | 282 | 90 | 0% (0) | 24% | $40,027 |
| 2023 | 341 | 103 | 0% (0) | None | $92,754 |
| 2022 | 269 | 113 | None | None | $58,910 |
| 2021 | 977 | 224 | 3% (27) | None | $145,832 |
| 2020 | 1,410 | 216 | 6% (79) | None | $242,019 |
| 2019 | 799 | 170 | 4% (30) | None | $108,666 |
| 2018 | 138 | 76 | None | 42% | $35,744 |
| 2017 | 352 | 107 | 0% (0) | 56% | $96,122 |
| 2016 | 454 | 149 | 0% (0) | 55% | $104,542 |
| 2015 | 499 | 163 | 0% (0) | 54% | $129,616 |
| 2014 | 472 | 157 | 0% (0) | 55% | $112,251 |
| 2013 | 531 | 182 | None | 58% | $111,802 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 9 drugs
| Trelegy Ellipta | 33 | $38,407 | $1,164 |
| Jardiance | 11 | $6,938 | $631 |
| Azelastine | 11 | $472 | $43 |
| Rosuvastatin | 26 | $342 | $13 |
| Metformin Hcl Er | 14 | $319 | $23 |
| Pantoprazole | 11 | $249 | $23 |
| Montelukast | 14 | $157 | $11 |
| Amlodipine Besylate | 12 | $51 | $4 |
| Prednisone | 11 | $25 | $2 |
2022: 5 drugs
| Trelegy Ellipta | 21 | $24,336 | $1,159 |
| Albuterol Sulfate Hfa | 18 | $606 | $34 |
| Metformin Hcl Er | 11 | $243 | $22 |
| Lisinopril | 13 | $104 | $8 |
| Levocetirizine Dihydrochloride | 12 | $96 | $8 |
2021: 23 drugs
| Trelegy Ellipta | 15 | $23,896 | $1,593 |
| Breo Ellipta | 21 | $20,219 | $963 |
| Wixela Inhub | 12 | $4,971 | $414 |
| Ezetimibe | 23 | $1,532 | $67 |
| Rosuvastatin | 41 | $1,288 | $31 |
| Hydrocodone-Acetaminophen | 27 | $883 | $33 |
| Chlorthalidone | 24 | $803 | $33 |
| Albuterol Sulfate Hfa | 18 | $786 | $44 |
| Atorvastatin | 59 | $779 | $13 |
| Levothyroxine | 40 | $656 | $16 |
| Montelukast | 41 | $600 | $15 |
| Losartan | 35 | $469 | $13 |
| Gabapentin | 11 | $380 | $35 |
| Omeprazole | 27 | $378 | $14 |
| Fenofibrate | 13 | $322 | $25 |
| Fluticasone Propionate | 15 | $302 | $20 |
| Bupropion Xl | 11 | $188 | $17 |
| Simvastatin | 19 | $161 | $8 |
| Metformin Hcl Er | 19 | $147 | $8 |
| Amlodipine Besylate | 37 | $115 | $3 |
| Lisinopril | 23 | $106 | $5 |
| Hydrochlorothiazide | 23 | $66 | $3 |
| Metformin | 16 | $61 | $4 |
2020: 41 drugs
| Breo Ellipta | 28 | $24,640 | $880 |
| Trelegy Ellipta | 12 | $17,551 | $1,463 |
| Symbicort | 19 | $12,541 | $660 |
| Aciphex | 12 | $6,755 | $563 |
| Dulera | 11 | $6,725 | $611 |
| Rosuvastatin | 52 | $3,733 | $72 |
| Fluticasone-Salmeterol | 12 | $3,456 | $288 |
| Ezetimibe | 32 | $2,576 | $81 |
| Azelastine-Fluticasone | 11 | $2,356 | $214 |
| Hydrocodone-Acetaminophen | 73 | $2,092 | $29 |
| Levothyroxine | 62 | $1,345 | $22 |
| Atorvastatin | 63 | $1,268 | $20 |
| Olmesartan Medoxomil | 12 | $1,217 | $101 |
| Albuterol Sulfate Hfa | 24 | $1,135 | $47 |
| Chlorthalidone | 25 | $1,084 | $43 |
| Montelukast | 47 | $826 | $18 |
| Azelastine | 12 | $819 | $68 |
| Gabapentin | 21 | $731 | $35 |
| Olopatadine | 15 | $670 | $45 |
| Omeprazole | 32 | $633 | $20 |
| Losartan | 51 | $598 | $12 |
| Bupropion Xl | 21 | $443 | $21 |
| Potassium Chloride | 21 | $420 | $20 |
| Fluticasone Propionate | 20 | $402 | $20 |
| Metoprolol | 16 | $331 | $21 |
| Tamsulosin | 19 | $287 | $15 |
| Pantoprazole | 11 | $265 | $24 |
| Sertraline | 21 | $226 | $11 |
| Simvastatin | 19 | $185 | $10 |
| Amlodipine Besylate | 31 | $165 | $5 |
| Metformin Hcl Er | 22 | $156 | $7 |
| Hydrochlorothiazide | 29 | $138 | $5 |
| Lisinopril | 24 | $138 | $6 |
| Lovastatin | 14 | $137 | $10 |
| Alprazolam | 15 | $109 | $7 |
| Lorazepam | 25 | $103 | $4 |
| Metoprolol | 14 | $102 | $7 |
| Azithromycin | 13 | $87 | $7 |
| Zolpidem | 22 | $60 | $3 |
| Metformin | 12 | $44 | $4 |
| Prednisone | 12 | $27 | $2 |
2019: 23 drugs
| Breo Ellipta | 30 | $20,316 | $677 |
| Symbicort | 22 | $13,705 | $623 |
| Trelegy Ellipta | 11 | $9,479 | $862 |
| Dulera | 12 | $6,723 | $560 |
| Rosuvastatin | 32 | $3,323 | $104 |
| Ezetimibe | 22 | $1,776 | $81 |
| Atorvastatin | 49 | $1,017 | $21 |
| Azelastine | 16 | $915 | $57 |
| Hydrocodone-Acetaminophen | 26 | $759 | $29 |
| Montelukast | 40 | $744 | $19 |
| Chlorthalidone | 18 | $627 | $35 |
| Omeprazole | 11 | $430 | $39 |
| Losartan | 26 | $312 | $12 |
| Potassium Chloride | 12 | $274 | $23 |
| Bupropion Xl | 15 | $264 | $18 |
| Fluticasone Propionate | 17 | $241 | $14 |
| Azithromycin | 25 | $219 | $9 |
| Metformin Hcl Er | 26 | $171 | $7 |
| Amlodipine Besylate | 16 | $160 | $10 |
| Simvastatin | 11 | $148 | $13 |
| Zolpidem | 12 | $101 | $8 |
| Prednisone | 18 | $55 | $3 |
| Lorazepam | 13 | $48 | $4 |
2018: 3 drugs
| Advair Diskus | 18 | $10,895 | $605 |
| Montelukast | 14 | $284 | $20 |
| Fluticasone Propionate | 11 | $272 | $25 |
2017: 8 drugs
| Advair Diskus | 54 | $34,768 | $644 |
| Dulera | 51 | $27,300 | $535 |
| Spiriva Respimat | 17 | $11,427 | $672 |
| Asmanex Hfa | 15 | $4,607 | $307 |
| Fluticasone Propionate | 48 | $1,062 | $22 |
| Ventolin Hfa | 25 | $1,015 | $41 |
| Montelukast | 27 | $625 | $23 |
| Metformin Hcl Er | 20 | $180 | $9 |
2016: 9 drugs
| Dulera | 80 | $31,547 | $394 |
| Advair Diskus | 46 | $27,156 | $590 |
| Spiriva Respimat | 36 | $16,269 | $452 |
| Fluticasone Propionate | 85 | $1,507 | $18 |
| Ventolin Hfa | 28 | $1,190 | $42 |
| Azelastine | 15 | $1,024 | $68 |
| Montelukast | 35 | $1,000 | $29 |
| Proair Hfa | 14 | $506 | $36 |
| Metformin Hcl Er | 12 | $108 | $9 |
2015: 12 drugs
| Dulera | 83 | $45,458 | $548 |
| Advair Diskus | 37 | $27,133 | $733 |
| Spiriva | 38 | $24,967 | $657 |
| Asmanex | 15 | $5,812 | $387 |
| Qvar | 27 | $3,572 | $132 |
| Fluticasone Propionate | 86 | $2,342 | $27 |
| Montelukast | 36 | $1,571 | $44 |
| Proair Hfa | 38 | $1,365 | $36 |
| Azelastine | 19 | $1,321 | $70 |
| Ipratropium | 11 | $373 | $34 |
| Prednisone | 18 | $320 | $18 |
| Lisinopril | 12 | $140 | $12 |
2014: 9 drugs
| Dulera | 84 | $44,263 | $527 |
| Advair Diskus | 48 | $27,161 | $566 |
| Spiriva | 33 | $16,084 | $487 |
| Asmanex | 11 | $4,393 | $399 |
| Qvar | 26 | $3,337 | $128 |
| Fluticasone Propionate | 85 | $2,808 | $33 |
| Montelukast | 26 | $1,476 | $57 |
| Proair Hfa | 28 | $871 | $31 |
| Prednisone | 27 | $323 | $12 |
2013: 12 drugs
| Dulera | 78 | $36,341 | $466 |
| Advair Diskus | 42 | $27,362 | $651 |
| Spiriva | 56 | $22,891 | $409 |
| Fluticasone Propionate | 98 | $3,260 | $33 |
| Epipen 2-Pak | 12 | $3,235 | $270 |
| Qvar | 26 | $3,089 | $119 |
| Azelastine | 12 | $1,229 | $102 |
| Proair Hfa | 37 | $1,095 | $30 |
| Montelukast | 18 | $1,025 | $57 |
| Ipratropium | 11 | $464 | $42 |
| Prednisone | 43 | $389 | $9 |
| Azithromycin | 11 | $126 | $11 |
Money from drug and device companies
$4,618 in 2025
| 2025 | 11 | 40 | $3,050 | $4,618 |
| 2024 | 15 | 49 | $1,306 | $2,671 |
| 2023 | 16 | 89 | $7,150 | $9,378 |
| 2022 | 23 | 78 | $9,830 | $11,909 |
| 2021 | 22 | 82 | None | $2,363 |
| 2020 | 15 | 35 | None | $958 |
| 2019 | 22 | 127 | None | $3,057 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| AstraZeneca Pharmaceuticals LP | Fasenra | $3,441 | 10 payments
|
| Inspire Medical Systems | Inspire | $457 | 5 payments
|
| Amgen | Tezspire | $302 | 9 payments
|
| Johnson & Johnson Health Care Systems | Stelara | $139 | 1 payment
|
| Genzyme | Dupixent | $58 | 2 payments
|
| Resmed | Airsense | $50 | 1 payment
|
See all 34 published payments
| Amgen | Meals · 2025-12-16 | Tezspire | $19 |
| Amgen | Meals · 2025-12-02 | Tezspire | $9 |
| Novartis Pharmaceuticals | Meals · 2025-11-11 | Rhapsido | $21 |
| Octapharma USA | Meals · 2025-11-04 | Cutaquig | $37 |
| Amgen | Meals · 2025-10-31 | Tezspire | $30 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-10-30 | None | $40 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-10-28 | Tezspire | $17 |
| AstraZeneca Pharmaceuticals LP | Paid to speak or teach · 2025-10-20 | Fasenra | $2,800 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-10-16 | Fasenra | $125 |
| AstraZeneca Pharmaceuticals LP | Travel · 2025-10-16 | Fasenra | $70 |
| Inspire Medical Systems | Meals · 2025-10-15 | Inspire | $4 |
| Genzyme | Meals · 2025-10-14 | Dupixent | $15 |
| Inspire Medical Systems | Meals · 2025-10-08 | Inspire | $67 |
| Inspire Medical Systems | Meals · 2025-09-29 | Inspire | $136 |
| Amgen | Meals · 2025-09-24 | None | $50 |
| Amgen | Meals · 2025-09-23 | Tezspire | $19 |
| Ionis Pharmaceuticals | Meals · 2025-09-23 | Dawnzera | $39 |
| AstraZeneca Pharmaceuticals LP | Paid to speak or teach · 2025-07-31 | Fasenra | $250 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-06-11 | Tezspire | $20 |
| Novo Nordisk | Meals · 2025-06-04 | Wegovy | $29 |
| Resmed | Meals · 2025-06-03 | Airsense | $50 |
| Johnson & Johnson Health Care Systems | Meals · 2025-05-15 | Stelara | $139 |
| GlaxoSmithKline | Meals · 2025-05-07 | Nucala | $18 |
| Amgen | Meals · 2025-05-07 | Tezspire | $5 |
| Amgen | Meals · 2025-05-07 | Tezspire | $12 |
| Genzyme | Meals · 2025-04-24 | Dupixent | $44 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-04-23 | Tezspire | $52 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-04-08 | None | $46 |
| Amgen | Meals · 2025-03-01 | Tezspire | $112 |
| GlaxoSmithKline | Meals · 2025-02-25 | Nucala | $26 |
| Inspire Medical Systems | Meals · 2025-02-20 | Inspire | $123 |
| Inspire Medical Systems | Meals · 2025-02-18 | Inspire | $127 |
| Amgen | Meals · 2025-02-04 | None | $46 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-01-08 | Tezspire | $22 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $2,671
| GlaxoSmithKline | Nucala | $1,573 | 10 payments
|
| AstraZeneca Pharmaceuticals LP | Fasenra | $335 | 14 payments
|
| Amgen | Tezspire | $241 | 9 payments
|
| Inspire Medical Systems | Inspire | $168 | 3 payments
|
| Genzyme | Dupixent | $81 | 2 payments
|
| Philips North America | (Di2) Nasal Masks - Over the Head | $57 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $41 | 2 payments
|
| Resmed | Airsense | $40 | 1 payment
|
| Regeneron Healthcare Solutions | Dupixent | $34 | 1 payment
|
| Greer Laboratories | Oralair | $23 | 1 payment
|
| Pfizer | Paxlovid | $23 | 1 payment
|
| Electromed | Smartvest | $19 | 1 payment
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $17 | 1 payment
|
| Octapharma USA | Cutaquig | $13 | 1 payment
|
| ADMA BioManufacturing | None | $6 | 1 payment
|
2023: $9,378
| GlaxoSmithKline | Nucala | $7,713 | 21 payments
|
| AstraZeneca Pharmaceuticals LP | Fasenra | $676 | 19 payments
|
| Genzyme | Dupixent | $222 | 4 payments
|
| Regeneron Healthcare Solutions | Dupixent | $176 | 6 payments
|
| Amgen | Tezspire | $162 | 8 payments
|
| Resmed | Airsense | $137 | 2 payments
|
| Genentech USA | Xolair | $66 | 3 payments
|
| MannKind | Afrezza | $31 | 1 payment
|
| Takeda Pharmaceuticals U.S.A. | Takhzyro | $31 | 1 payment
|
| Pfizer | Nurtec Odt | $28 | 1 payment
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $28 | 1 payment
|
| Beta Bionics | Ilet Bionic Pancreas | $27 | 1 payment
|
| BioCryst US Sales Co. | Orladeyo | $26 | 1 payment
|
| Radius Health | Tymlos | $25 | 1 payment
|
| Abbvie | Ubrelvy | $16 | 1 payment
|
| Sanofi-Aventis U.S. | Soliqua 100/33 | $16 | 1 payment
|
2022: $11,909
| GlaxoSmithKline | Nucala | $9,651 | 18 payments
|
| Genzyme | Dupixent | $1,125 | 6 payments
|
| Amgen | Tezspire | $267 | 17 payments
|
| Regeneron Healthcare Solutions | Dupixent | $96 | 2 payments
|
| Biohaven Pharmaceutical Holding Company | Nurtec Odt | $79 | 3 payments
|
| Corcept Therapeutics | Korlym | $76 | 3 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $75 | 3 payments
|
| Novartis Pharmaceuticals | Xolair | $72 | 4 payments
|
| ALK-Abello | Odactra | $60 | 2 payments
|
| AstraZeneca Pharmaceuticals LP | Fasenra | $59 | 3 payments
|
| Genentech USA | Xolair | $46 | 3 payments
|
| Xeris Pharmaceuticals | None | $42 | 2 payments
|
| Alexion Pharmaceuticals | Strensiq | $37 | 2 payments
|
| Amryt Pharma Holdings | Mycapssa | $29 | 1 payment
|
| Mannkind | Afrezza | $27 | 1 payment
|
| Takeda Pharmaceuticals U.S.A. | Cuvitru | $26 | 1 payment
|
| Lilly USA | Baqsimi | $24 | 1 payment
|
| Aimmune Therapeutics | Palforzia | $22 | 1 payment
|
| Bayer HealthCare Pharmaceuticals | Kerendia | $20 | 1 payment
|
| kaleo | Auvi-Q | $20 | 1 payment
|
| Teva Pharmaceuticals USA | Airduo Digihaler | $20 | 1 payment
|
| Alnylam Pharmaceuticals | Oxlumo | $19 | 1 payment
|
| OptiNose US | Xhance | $17 | 1 payment
|
2021: $2,363
| GlaxoSmithKline | Nucala | $507 | 16 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $307 | 12 payments
|
| Regeneron Healthcare Solutions | Dupixent | $285 | 5 payments
|
| AstraZeneca Pharmaceuticals LP | Fasenra | $256 | 7 payments
|
| Amgen | Evenity | $229 | 6 payments
|
| Genzyme | Dupixent | $142 | 3 payments
|
| Acerta Pharma | None | $125 | 1 payment
|
| Biohaven Pharmaceuticals | Nurtec Odt | $75 | 3 payments
|
| Genentech USA | Xolair | $50 | 3 payments
|
| OptiNose US | Xhance | $46 | 2 payments
|
| Xeris Pharmaceuticals | Gvoke Pfs | $45 | 2 payments
|
| MannKind | Afrezza | $39 | 2 payments
|
| Teva Pharmaceuticals USA | Cinqair | $38 | 2 payments
|
| Novo Nordisk | Ozempic | $37 | 2 payments
|
| Lilly USA | Humulin | $31 | 1 payment
|
| Radius Health | Tymlos | $28 | 1 payment
|
| Becton Dickinson and | Bd Nano | $26 | 1 payment
|
| Bayer HealthCare Pharmaceuticals | Kerendia | $23 | 1 payment
|
| Clarus Therapeutics | Jatenzo | $22 | 1 payment
|
| Novartis Pharmaceuticals | Xolair | $20 | 1 payment
|
| kaleo | Auvi-Q | $19 | 1 payment
|
| Merck Sharp & Dohme | Januvia | $14 | 1 payment
|
2020: $958
| GlaxoSmithKline | Nucala | $292 | 9 payments
|
| Amgen | Prolia | $207 | 4 payments
|
| Boehringer Ingelheim Pharmaceuticals | Spiriva Respimat | $77 | 3 payments
|
| AstraZeneca Pharmaceuticals LP | Fasenra | $64 | 3 payments
|
| OptiNose US | Xhance | $58 | 3 payments
|
| Lilly USA | Jardiance | $56 | 3 payments
|
| Takeda Pharmaceuticals U.S.A. | Cuvitru | $45 | 2 payments
|
| Regeneron Healthcare Solutions | Dupixent | $32 | 1 payment
|
| Alexion Pharmaceuticals | Strensiq | $25 | 1 payment
|
| Merck Sharp & Dohme | Januvia | $19 | 1 payment
|
| Genzyme | Dupixent | $19 | 1 payment
|
| iRhythm Technologies | Zio Patch | $17 | 1 payment
|
| Novartis Pharmaceuticals | Xolair | $17 | 1 payment
|
| Genentech USA | Xolair | $16 | 1 payment
|
| Pfizer | Eucrisa | $14 | 1 payment
|
2019: $3,057
| GlaxoSmithKline | Nucala | $622 | 27 payments
|
| AstraZeneca Pharmaceuticals LP | Fasenra | $442 | 14 payments
|
| Amgen | Evenity | $412 | 10 payments
|
| Genzyme | Dupixent | $351 | 3 payments
|
| Teva Pharmaceuticals USA | Cinqair | $206 | 9 payments
|
| Novo Nordisk | Saxenda | $186 | 13 payments
|
| Regeneron Healthcare Solutions | Dupixent | $172 | 4 payments
|
| Mannkind | Afrezza | $117 | 7 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $83 | 5 payments
|
| Lilly USA | Trulicity | $68 | 3 payments
|
| Nalpropion Pharmaceuticals | Contrave | $59 | 3 payments
|
| Companion Medical | Inpen | $52 | 3 payments
|
| Merck Sharp & Dohme | Januvia | $47 | 3 payments
|
| Novartis Pharmaceuticals | Xolair | $42 | 2 payments
|
| Sanofi-Aventis U.S. | Soliqua 100/33 | $42 | 2 payments
|
| Octapharma USA | Cutaquig | $38 | 1 payment
|
| Insulet | Omnipod | $26 | 2 payments
|
| Shire North American Group | Cuvitru | $25 | 1 payment
|
| Circassia Pharmaceuticals | Tudorza Pressair | $20 | 1 payment
|
| OptiNose US | Xhance | $19 | 1 payment
|
| ALK-Abello | Odactra | $14 | 1 payment
|
| Tandem Diabetes Care | T-Slim Insulin Pump | $14 | 1 payment
|
Professional record
- NPI
- 1285801787
- Licence
- CA A103029California A103029: Current · expires 2027-07-31
- Group
- Jiva Health Inc
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207RA0201X (207RA0201X)
- Mailing address
- 2182 East St, Concord, CA, 94520
- NPI first listed
- 2008-05-14
- NPI last updated
- 2024-07-25
- NPI record certified
- 2024-07-25
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 5173 Lone Tree Way, Antioch, CA, 94531 · 978 2nd St Ste 220, Lafayette, CA, 94549